Clinical Trial Update: Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety and efficacy of ustekinumab in palmo-plantar pustular psoriasis and palmo-plantar pustulosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmo-plantar Pustular Psoriasis
• Palmo-plantar Pustulosis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Palmo-Plantar Pustular Psoriasis, Palmo-Plantar Pustulosis | Phase 3 | Status: TERMINATED